For several years now, Across Health has been running a unique digital landscape survey among life sciences leaders in EMEA. This year’s edition of the Digital Barometer has taken a global perspective with exclusive results from our key markets EMEA, US and China. It gives you a 360° view on the status, challenges and future of “The New Normal” in life sciences, i.e. when digital communication is no longer new, but is the norm.
How Data Empowers the Member-Centric Enterprise (AHIP Presentation)Mandi Bishop
Presentation at AHIP OpsTech and Consumer Forum, focusing on the 7Vs of data driving the member-centric health plan enterprise: velocity, volume, variability, vulnerability, veracity, volunteered, and viscosity.
Webinar materials prepared for Association for Community-Affilitated Plans (ACAP). Healthcare consumerism is coming - are you prepared? As industry changes, so consumers adapt, and today's consumers have a world of information and engagement tools at their fingertips. In this webinar, learn how health insurance organizations and other healthcare companies can increase and improve their consumer experience through meaningful engagement, through social media.
How Big Data, Smart Devices and Wearables Will Save Lives: Revealing the Emer...Enspektos, LLC
Big Data, mobile, sensors and human experts are being combined to develop next-generation wellness solutions that may help us win the war against diseases like heart disease that are caused by poor health habits. Read this introduction to the emerging TechnoWellness revolution and how it could save lives.
Caregiving Innovation Frontiers: A universal need, a growing opportunity — le...Longevity Network
Can 40 million caregivers count on you?
Where can I find reliable help with meals and medications? What does this bill mean, and will my insurance cover it? And how can I help Mom and Dad stay safe and healthy? As people live longer lives, questions like these touch us all. According to the 2015 report “Caregiving in the U.S.,” an AARP and National Alliance for Caregiving study, nearly 40 million Americans in 2014 were providing unpaid care to people who are older, disabled, or otherwise in need of assistance. A quarter were millennials and half were under the age of 50. Some call it “informal” care, but there’s nothing informal about the emotional, financial and day-to-day stress such a role can involve or the growing gap between the number of caregivers and the number of care recipients. By 2020, 117 million Americans are expected to need assistance of some kind, yet the overall number of caregivers is only expected to reach 45 million.
How Trends Drive Innovation in Product DesignBresslergroup
Open-ended product design challenges are, well, challenging! A client may come to a design strategist with no clear direction beyond their intent to disrupt an industry. Trend research is one of the tools we use to come up with new ways to innovate.
In this talk during DesignPhiladelphia 2018, Lead Design Strategist, Ryan Chen, presented a conceptual case study from the personal care industry to show how Bresslergroup might use trend research to lead to insights that lead to novel product concepts.
Chen began his talk with an overview of ten socio-cultural megatrends he’s identified that are going to influence consumer value and behavior -- and impact product design -- into the next decade.
Read more at "Five Global Megatrends Reshaping Product Design": http://bit.ly/2QKe5jJ
With an M.B.A. from the University of Oxford and a B.A. (Industrial Design) from National University of Singapore, Ryan Chen possesses a unique combination of creativity and business acumen. Before joining Bresslergroup, Ryan was a Lead Designer at Tupperware and Senior Designer at Philips Design. His work has won prestigious international awards including the iF Design Award, Red Dot, and Good Design.
How Data Empowers the Member-Centric Enterprise (AHIP Presentation)Mandi Bishop
Presentation at AHIP OpsTech and Consumer Forum, focusing on the 7Vs of data driving the member-centric health plan enterprise: velocity, volume, variability, vulnerability, veracity, volunteered, and viscosity.
Webinar materials prepared for Association for Community-Affilitated Plans (ACAP). Healthcare consumerism is coming - are you prepared? As industry changes, so consumers adapt, and today's consumers have a world of information and engagement tools at their fingertips. In this webinar, learn how health insurance organizations and other healthcare companies can increase and improve their consumer experience through meaningful engagement, through social media.
How Big Data, Smart Devices and Wearables Will Save Lives: Revealing the Emer...Enspektos, LLC
Big Data, mobile, sensors and human experts are being combined to develop next-generation wellness solutions that may help us win the war against diseases like heart disease that are caused by poor health habits. Read this introduction to the emerging TechnoWellness revolution and how it could save lives.
Caregiving Innovation Frontiers: A universal need, a growing opportunity — le...Longevity Network
Can 40 million caregivers count on you?
Where can I find reliable help with meals and medications? What does this bill mean, and will my insurance cover it? And how can I help Mom and Dad stay safe and healthy? As people live longer lives, questions like these touch us all. According to the 2015 report “Caregiving in the U.S.,” an AARP and National Alliance for Caregiving study, nearly 40 million Americans in 2014 were providing unpaid care to people who are older, disabled, or otherwise in need of assistance. A quarter were millennials and half were under the age of 50. Some call it “informal” care, but there’s nothing informal about the emotional, financial and day-to-day stress such a role can involve or the growing gap between the number of caregivers and the number of care recipients. By 2020, 117 million Americans are expected to need assistance of some kind, yet the overall number of caregivers is only expected to reach 45 million.
How Trends Drive Innovation in Product DesignBresslergroup
Open-ended product design challenges are, well, challenging! A client may come to a design strategist with no clear direction beyond their intent to disrupt an industry. Trend research is one of the tools we use to come up with new ways to innovate.
In this talk during DesignPhiladelphia 2018, Lead Design Strategist, Ryan Chen, presented a conceptual case study from the personal care industry to show how Bresslergroup might use trend research to lead to insights that lead to novel product concepts.
Chen began his talk with an overview of ten socio-cultural megatrends he’s identified that are going to influence consumer value and behavior -- and impact product design -- into the next decade.
Read more at "Five Global Megatrends Reshaping Product Design": http://bit.ly/2QKe5jJ
With an M.B.A. from the University of Oxford and a B.A. (Industrial Design) from National University of Singapore, Ryan Chen possesses a unique combination of creativity and business acumen. Before joining Bresslergroup, Ryan was a Lead Designer at Tupperware and Senior Designer at Philips Design. His work has won prestigious international awards including the iF Design Award, Red Dot, and Good Design.
By 2020, the number of Americans who are expected to need assistance is projected to be 117 million, yet the number of unpaid family caregivers is expected to reach only 45 million. We need technology more than ever to bridge the gap. Project Catalyst, in collaboration with HITLAB, conducted a survey with over 1,000 caregivers, aimed at identifying their technology interest and usage. The research found that caregivers have a high interest in using technology to care for their loved ones – 71 percent of survey participants expressed interest in using technology to support caregiving activities while less than 10 percent have currently or previously used caregiving technology. Adoption rates are low due to a range of factors including lack of awareness, high cost, perception that technology may not be a benefit, and lack of time to learn and adapt new technologies. This presents an opportunity for the technology industry to leapfrog existing offerings and provide viable alternatives to the 40 million caregivers actively seeking ways to lessen their workload.
How do we see the healthcare's digital future and its impact on our lives?Jane Vita
"Healthcare is undergoing major changes spurred on by, but not limited to, technology.
Digitalisation is changing the way we think about health, what taking care of it really entails, our personal role in healthcare systems and the way we interact with technology in the context of health.
In many ways, we are entering a post-institutional age of increased personal responsibility, which presents healthcare service providers and other players in the field with major opportunities and great risks. Technology has the potential to empower people and help them become more active in the management of their and their families’ health. This will change the relationship of the patient and the caregiver in profound ways." Mirkka Länsisalo
A co-creation with Mirkka Läansisalo and Sala Heinänen, at Futurice.
The 10 most innovative pharma and life sciences solutions providers jan 2018Merry D'souza
With great enthusiasm Insights Success has selected some of the most prominent organizations around the globe in the issue of “The 10 Most Innovative Pharma and life sciences Solution Providers 2018,”
Across Health Multichannel Maturometer 2016Across Health
We are pleased to present you with the 8th Across Health Multichannel Maturometer in Life Sciences, which covers the 4 key dimensions of digital maturity: strategy & organization, business processes & technology, multichannel integration and measurement.
If you only look at the averages, the 2016 results are very much a copy-paste of the previous years. At 13%, average satisfaction levels remain at all-time-low levels, while average digital marketing budgets (15.7%) are status-quo for the 4th year running. Skill levels continue to be low, key channels are very similar, etc etc.
However, if you look beyond these averages, some early leaders can be identified. Indeed, 15% states that digital transformation is happening fast. In other words, while most of the eggs in the hatchery are still closed, some “chickens” have already hatched.
We saw the same trend in 2015, where the top 10% is outperforming the average company significantly (http://bit.ly/29qk2lg), except for key “pain points” like mix optimization, campaign management and KPIs.
And if you look at the 2015-2016 comparison (p26), you can again infer that there is some activity in the other eggs too…Indeed, customer databases are increasingly crosschannel, while the pain related to execution (mix planning and campaign management platforms) – and the lack of training - are felt much harder than in 2015…in other words, the other eggs could hatch soon…and MCM will never be the same again!
Happy reading & holidays!
Fonny
Across Health Multichannel Maturometer 2015Across Health
To view the recorded webinar please visit: http://bit.ly/1cLENV1
We are pleased to present you with the 7th Across Health survey on multichannel in life sciences, previously known as the Barometer.
We renamed it to the Maturometer, to reflect the content more aptly. Indeed, we have revamped and simplified the Barometer, by clustering all questions around 4 key dimensions of digital maturity: strategy & organization, business processes & technology, multichannel integration and measurement. We trust this will give you a structured view and will provide you with actionable input to take your company to the next level.
Generally speaking, the 2015 results are in line with 2014 – with historically low satisfaction levels and the 4th consecutive year of plateauing budgets (at a low level). US and Europe are most pessimistic; emerging markets appear to be more positive overall – but that may be due to their relatively new entry into this space.
We do see however a difference in speed in the market – around 14% is implementing multichannel very quickly, is spending significantly more than the average, and feels comfortable with impact measurement etc…multichannel @ multispeed!
We trust that these early leaders will soon be followed by the early majority…my guess is that 2015 REALLY is the end of the beginning!
Fonny Schenck
CEO, Across Health
Adobe Personalization 2020 Survey of Consumers and MarketersAdobe
In January and February 2020, Adobe surveyed over 400 digital marketers and 1,000 adult consumers on topics related to digital experience personalization. Questions cover the priority of personalization, budget allocation, use cases, benefits seen including return on investment, and consumer relationships with brands and personalization across a variety of devices.
Futurists have long predicted a world in which the products around us have minds of their own, from talking televisions to smart fridges. Now, at last, that vision is beginning to materialise, thanks to the plummeting cost of computing components and the ubiquity of wireless communications.
"Developing smart products" is a new report sponsored by Cognizant, that explores the commercial, organisational and strategic impact of smart products on the companies that develop them.
April 2013 StartUp Health Insights Funding ReportStartUp Health
See StartUp Health Insights (http://www.startuphealth.com/insights) for the most comprehensive digital health funding database. Apply to StartUp Health Academy here: http://www.startuphealth.com/about-us/application/
Adobe Digital Index’s (ADI) “State Of Banking” report finds that banks in the United States are behind other countries when it comes to the adoption of mobile technology to enhance the customer experience.
For the fifth year running, Across Health is presenting you with its truly unique digital landscape overview among life sciences in Europe, US and emerging markets. The Digital Barometer gives you a 360°view on the status, challenges and future of “The New Normal”, i.e. where digital has become a commodity & is fully integrated in the overall channel mix.
2015 Healthcare IT Vision: Top 5 eHealth Trendsaccenture
Read about the five key Health IT trends and innovations shaping the business landscape in 2015 and beyond according to Accenture’s Healthcare Technology Vision 2015.
The 10 companies booming in healthcare sector smallinsightscare
Development is a continuous process in any sector. It brings in more comfort, more precision, and more enhanced way of living.Acknowledging the remarkable contribution of the leading companies in the care sector, we bring to you the special issue of “The 10 Companies Booming in Healthcare Sector”.
Across Health Multichannel Maturometer 2017Across Health
Across Health is pleased to present you with the state of the
multichannel landscape in life sciences in Europe, US and
emerging markets – now in its ninth year.
This year we took a wider view at where digital dollars are going – particularly at patient engagement and digital innovation. Results show that global and local have different views on their effectiveness and importance…
Also, while we see budgets and teams growing (after five years!), satisfaction remains (incredibly) low.
To learn more please watch the recorded version of our webinar: https://goo.gl/Q275oq
According to a new survey of more than 115 eCommerce & multi-channel executives from major global retail brands, European retailers see mobile as not only the biggest growth opportunity, but also the area that will change the most in the next one to two years.
By 2020, the number of Americans who are expected to need assistance is projected to be 117 million, yet the number of unpaid family caregivers is expected to reach only 45 million. We need technology more than ever to bridge the gap. Project Catalyst, in collaboration with HITLAB, conducted a survey with over 1,000 caregivers, aimed at identifying their technology interest and usage. The research found that caregivers have a high interest in using technology to care for their loved ones – 71 percent of survey participants expressed interest in using technology to support caregiving activities while less than 10 percent have currently or previously used caregiving technology. Adoption rates are low due to a range of factors including lack of awareness, high cost, perception that technology may not be a benefit, and lack of time to learn and adapt new technologies. This presents an opportunity for the technology industry to leapfrog existing offerings and provide viable alternatives to the 40 million caregivers actively seeking ways to lessen their workload.
How do we see the healthcare's digital future and its impact on our lives?Jane Vita
"Healthcare is undergoing major changes spurred on by, but not limited to, technology.
Digitalisation is changing the way we think about health, what taking care of it really entails, our personal role in healthcare systems and the way we interact with technology in the context of health.
In many ways, we are entering a post-institutional age of increased personal responsibility, which presents healthcare service providers and other players in the field with major opportunities and great risks. Technology has the potential to empower people and help them become more active in the management of their and their families’ health. This will change the relationship of the patient and the caregiver in profound ways." Mirkka Länsisalo
A co-creation with Mirkka Läansisalo and Sala Heinänen, at Futurice.
The 10 most innovative pharma and life sciences solutions providers jan 2018Merry D'souza
With great enthusiasm Insights Success has selected some of the most prominent organizations around the globe in the issue of “The 10 Most Innovative Pharma and life sciences Solution Providers 2018,”
Across Health Multichannel Maturometer 2016Across Health
We are pleased to present you with the 8th Across Health Multichannel Maturometer in Life Sciences, which covers the 4 key dimensions of digital maturity: strategy & organization, business processes & technology, multichannel integration and measurement.
If you only look at the averages, the 2016 results are very much a copy-paste of the previous years. At 13%, average satisfaction levels remain at all-time-low levels, while average digital marketing budgets (15.7%) are status-quo for the 4th year running. Skill levels continue to be low, key channels are very similar, etc etc.
However, if you look beyond these averages, some early leaders can be identified. Indeed, 15% states that digital transformation is happening fast. In other words, while most of the eggs in the hatchery are still closed, some “chickens” have already hatched.
We saw the same trend in 2015, where the top 10% is outperforming the average company significantly (http://bit.ly/29qk2lg), except for key “pain points” like mix optimization, campaign management and KPIs.
And if you look at the 2015-2016 comparison (p26), you can again infer that there is some activity in the other eggs too…Indeed, customer databases are increasingly crosschannel, while the pain related to execution (mix planning and campaign management platforms) – and the lack of training - are felt much harder than in 2015…in other words, the other eggs could hatch soon…and MCM will never be the same again!
Happy reading & holidays!
Fonny
Across Health Multichannel Maturometer 2015Across Health
To view the recorded webinar please visit: http://bit.ly/1cLENV1
We are pleased to present you with the 7th Across Health survey on multichannel in life sciences, previously known as the Barometer.
We renamed it to the Maturometer, to reflect the content more aptly. Indeed, we have revamped and simplified the Barometer, by clustering all questions around 4 key dimensions of digital maturity: strategy & organization, business processes & technology, multichannel integration and measurement. We trust this will give you a structured view and will provide you with actionable input to take your company to the next level.
Generally speaking, the 2015 results are in line with 2014 – with historically low satisfaction levels and the 4th consecutive year of plateauing budgets (at a low level). US and Europe are most pessimistic; emerging markets appear to be more positive overall – but that may be due to their relatively new entry into this space.
We do see however a difference in speed in the market – around 14% is implementing multichannel very quickly, is spending significantly more than the average, and feels comfortable with impact measurement etc…multichannel @ multispeed!
We trust that these early leaders will soon be followed by the early majority…my guess is that 2015 REALLY is the end of the beginning!
Fonny Schenck
CEO, Across Health
Adobe Personalization 2020 Survey of Consumers and MarketersAdobe
In January and February 2020, Adobe surveyed over 400 digital marketers and 1,000 adult consumers on topics related to digital experience personalization. Questions cover the priority of personalization, budget allocation, use cases, benefits seen including return on investment, and consumer relationships with brands and personalization across a variety of devices.
Futurists have long predicted a world in which the products around us have minds of their own, from talking televisions to smart fridges. Now, at last, that vision is beginning to materialise, thanks to the plummeting cost of computing components and the ubiquity of wireless communications.
"Developing smart products" is a new report sponsored by Cognizant, that explores the commercial, organisational and strategic impact of smart products on the companies that develop them.
April 2013 StartUp Health Insights Funding ReportStartUp Health
See StartUp Health Insights (http://www.startuphealth.com/insights) for the most comprehensive digital health funding database. Apply to StartUp Health Academy here: http://www.startuphealth.com/about-us/application/
Adobe Digital Index’s (ADI) “State Of Banking” report finds that banks in the United States are behind other countries when it comes to the adoption of mobile technology to enhance the customer experience.
For the fifth year running, Across Health is presenting you with its truly unique digital landscape overview among life sciences in Europe, US and emerging markets. The Digital Barometer gives you a 360°view on the status, challenges and future of “The New Normal”, i.e. where digital has become a commodity & is fully integrated in the overall channel mix.
2015 Healthcare IT Vision: Top 5 eHealth Trendsaccenture
Read about the five key Health IT trends and innovations shaping the business landscape in 2015 and beyond according to Accenture’s Healthcare Technology Vision 2015.
The 10 companies booming in healthcare sector smallinsightscare
Development is a continuous process in any sector. It brings in more comfort, more precision, and more enhanced way of living.Acknowledging the remarkable contribution of the leading companies in the care sector, we bring to you the special issue of “The 10 Companies Booming in Healthcare Sector”.
Across Health Multichannel Maturometer 2017Across Health
Across Health is pleased to present you with the state of the
multichannel landscape in life sciences in Europe, US and
emerging markets – now in its ninth year.
This year we took a wider view at where digital dollars are going – particularly at patient engagement and digital innovation. Results show that global and local have different views on their effectiveness and importance…
Also, while we see budgets and teams growing (after five years!), satisfaction remains (incredibly) low.
To learn more please watch the recorded version of our webinar: https://goo.gl/Q275oq
According to a new survey of more than 115 eCommerce & multi-channel executives from major global retail brands, European retailers see mobile as not only the biggest growth opportunity, but also the area that will change the most in the next one to two years.
What can healthcare learn from the transformation which have taken place in other industries? What is the potential of digital for the pharmaceutical companies of tomorrow?
LinkedIn: Home to the Global Business EliteLinkedIn
The latest round of the Global Business Elite survey shows over a third of the world’s most influential and affluent people using LinkedIn at least once a month.
The research shows the same level of penetration for LinkedIn amongst the highest-level C-Suite executives, 118,000 of whom use the network daily. And the platform also reaches 58% of international business travellers.
Top business users are amongst LinkedIn’s most engaged and digitally savvy members, with 83% accessing content via a smartphone. And with high personal net worth and big business-purchase budgets, they represent the most valuable consumers on the planet.
FINN Partners Global State of Digital Health Q3 2022Levi Shapiro
Global State of Digital Health, Q3 2022, prepared by Finn Partners and Galen Growth.
While most analyses suggest digital health investment is declining, that’s a superficial assessment. Last year – when patients were separated from the health professional community – investors from all sectors jumped in with investments to learn and save their business models. That investment surge was from exuberance. Now, the monies being deployed are strategic. More important, 2022 numbers are far higher than the pre-pandemic equity invested in 2019.
While more than 60% of the total venture funding value comes from North America, on a regional level, the Middle East (primarily Israel by 92% and the United Arab Emirates) set record highs in venture funding in Q2 2022. Europe maintains momentum throughout 2022 and has not experienced the quarter-on-quarter decrease in venture funding seen in North America. Regions with increased investment correspond to established regulatory, public health and payer systems that prioritize digital health use. Israel – and Israeli-based entrepreneurs – need to keep their profiles high.
Introductory presentation to an EphMRA Masterclass workshop follow-up webinar given 6 December 2012. The original Masterclass workshop was delivered in Paris June 2012 at the EphMRA '360 Future' conference.
The full recorded webinar will be made available to EphMRA members later in 2013
Mobility, Analytics & Big Data for Life Sciencesjoemiles35
This article will focus on how life science and healthcare companies can leverage the significant innovations in mobile
devices, in memory computing, and realtime analytic technologies to drive down the cost of healthcare and improve
the accuracy and availability of information for business users, clinicians, physicians, nurses, and patients. These
innovations will enable the rapid analysis of vast amounts of data to deliver actionable insights that previously took
hours or even days to achieve, thus enabling a competitive business advantage and a superior patient outcome.
2018 ODH Health Plan Survey - Are Health Plans Ready for Innovation?ODH, Inc.
Shifting health plan landscape brings more competition focused on performance and value. Health care payers of all kinds must innovate, manage big data and harness new technology to deliver better performance at lower costs. Early results from this Survey of 180 commercial and Medicaid health plans feature population health management challenges and solutions, the use of data aggregation as a business strategy, resources to address complex populations, and the role of technology for health plans in the shift to value-based care.
Across Health Multichannel Maturometer 2018Across Health
Across Health is pleased to present you with the state of the multichannel landscape in life sciences in Europe, US and emerging markets – now in its tenth year. Results show that digitally trained staff numbers are still at historically low levels, and the same goes for other key enablers for digital transformation. Also, while we see budgets keep on growing, satisfaction remains low.
Presentation in conjunction with American Family on implementing and using analytics within the insurance industry. Presentation includes summary of usage survey within industry, common uses and approaches, and an implementation approach that leverages Six Sigma and Lean Manufacturing to put analytics in place.
Across Health - Key HCP and industry omnichannel engagement trends in life sc...Across Health
Ruud Kooi (MD Across Health) and Luisa Schirm (VP Global Accounts) share highlights from our latest Global Trends Report, including some of last year's most interesting insights pulled from our industry-leading Navigator365™ and Maturometer™ research. You can look forward to a unique snapshot of what biopharma and its HCP audiences have been thinking and doing in the omnichannel space in 2023, as well as a look ahead at what to expect in 2024 and beyond.
Key topics discussed:
- Enduring shifts in HCP channel & content affinity & impact
- HCP interest in & (dis)satisfaction with biopharma’s digital offerings
- The competitive landscape
- Insights and key regional trends for EU5, US & APAC
Watch the recorded webinar and access the full deck here:
http://tinyurl.com/yptwadcm
Across Health - Global HCP & competitor omnichannel trends in life sciences 2...Across Health
Fonny Schenck (Strategic Management Advisor) and Patrick Vidal (SVP Global Accounts) shared highlights from our 2022 Global Trends Report, including some of last year's most interesting insights pulled from our industry-leading Navigator365™ and Maturometer™ research. You can look forward to a unique snapshot of what biopharma and its HCP and payer audiences have been thinking and doing in the omnichannel space in 2022, as well as a look ahead at what to expect in 2023 and beyond.
Key topics included:
• Enduring shifts in HCP channel & content affinity & impact
• HCP interest in & (dis)satisfaction with biopharma’s digital offerings
• The competitive landscape
• Future scenarios
• Insights and key trends for EU5, US, LATAM & APAC
Watch the recorded webinar and access the full deck here: https://rb.gy/h1qu5x
Across Health - 'Omnichannel myopia' in the post-Covid era- The importance of...Across Health
Beverly Smet (VP Global Accounts) and Vanessa Huichard (Senior Strategy Consultant) advised on how to benchmark your brand for omnichannel leadership and how robust benchmarking can support you in sound business planning.
Key topics included:
• “Marketing myopia” – what’s in a name
• How the pandemic disrupted the landscape for Cx and OC effectiveness
• Creating a burning platform for Cx by adopting an outside-in perspective
• How robust benchmarking can support sound business planning: case example
Watch the recorded webinar and access the full deck here: https://rb.gy/guxkhq
Across Health - Navigator365™ product updates and plans for 2023Across Health
Pim ten Tusscher (CTO- Across Health) and Christophe Brock (Head of Impact – Across Health) gave a 40-minute update on the latest product developments, as well as a preview of our exciting plans for 2023!
Key topics included:
• Two new products: Navigator365™ Benchmark & Navigator365™ Payer
• A fully redesigned Navigator365™ Planner allowing you to plan and quantify your omnichannel plans
• A new iteration of Navigator365™ Core with a dedicated omnichannel launch section
• Two additions to our Omnitopia™ serious game offering: Field-Commercial and Medical
• A fully revised Missing Manual – the handbook for omnichannel excellence in the life sciences
• A sneak peek of our 2023 plans!
Watch the recorded webinar and access the full deck here: https://bit.ly/3BDnAew
Across Health - Omnichannel for Payers: A big opportunity for pharma Across Health
During our recent live webinar, David Ziedman (SVP Global Accounts) and Jason Cunningham (Senior Consultant) explored how omnichannel offers an untapped opportunity for pharma to connect with Payers more effectively.
Key topics included:
• Achieving the most impactful channel mix for this target group
• How does pharma’s digital offering compare to what Payers actually want?
• Channels used by Payers with the highest reach, impact and frequency (with insights from the recently launched Navigator365™ Payer)
• How benchmarking can tell us which companies are performing well (and not so well) in Omnichannel
Watch the recorded webinar and access the full deck here: http://bit.ly/3VpujQH
Across Health - Omnichannel Launch Excellence: Medical & Commercial best prac...Across Health
During last year’s webinar on the same topic we discussed our perspectives on post-C19 launch excellence, and we all agreed that the New Normal will never be the same. During this year’s webinar on Omnichannel Launch Excellence, Ruud Kooi (SVP Global Accounts) and Ben Harbour (Senior Consultant) discussed on how to optimize your omnichannel launch and discover solutions to some of the potential obstacles you might face.
Key topics included:
• How to create an evidence-based roadmap for Medical and Commercial omnichannel launch – at the international and local level
• 5 tips to optimize your Medical and Commercial omnichannel launch
• Case study: Preparing for a Medical and Commercial launch – challenges and solutions
Watch the recorded webinar and access the full deck here: http://bit.ly/3u0lcdz
Is biopharma ready for the New Normal and how far have we progressed along the path to omnichannel maturity? Fonny Schenck (MD Across Health, EVP Precision Value & Health) & Sander Geysen (Senior Consultant) will share the highlights of the 2022 Maturometer™ survey, giving you a unique overview of the current state of digital transformation within life science companies.
Key topics included:
(Digital) transformation: just “talking the talk”? Or well underway?
Key investment focus: channels, technologies, data, content, capabilities,…
Digital share of the go-to-market budget mix
Key barriers & drivers
Key priorities for continued success in the age of omnichannel excellence
Watch the recorded webinar and access the full deck here: https://bit.ly/3CjnQyZ
Post-COVID Omnichannel HCP engagement Romania – key trends.pdfAcross Health
In this webinar, Beverly Smet (SVP Global Accounts) and Pieterjan Dhondt (Associate Consultant) elaborated on some of the key trends in the Romanian specialty landscape, gathered from our Navigator365™ HCP Omnichannel affinity research.
Key topics included:
- How do Romanian HCPs compare to their EU5 colleagues?
- How did COVID19 affect the reach & impact of your promotional & medical channels?
- How satisfied are Romanian HCPs with pharma’s current digital offering?
Find out more here: https://bit.ly/3yUnFsm
Tips for your 2023 omnichannel budget planning.pdfAcross Health
Vladimir Rogiers (Senior Consultant) and Jan Keuppens (SVP Global Accounts) discovered how omnichannel thinking should be a key dimension of your 2023 business planning, as well as addressing key business questions and offering some essential tips and evidence.
Key topics included:
• Which channels, media and content do my customers prefer? And where does my brand do well (and not so well) versus the competition?
• How do I translate my strategic imperatives, leverage points and key segments into pragmatic customer journeys?
• What kind of budget should I set aside for this? What % should go to digital?
• What kind of business impact can I expect from my omnichannel plan? And how do I prepare for execution excellence?
Watch the recorded webinar and access the full deck here: https://bit.ly/3NH8nw8
Omnichannel launch excellence in the never normalAcross Health
Like many other things, launch excellence will never be the same again post-C19… Ruud Kooi (SVP Global Accounts) and Luisa Schirm (Senior Consultant) will show you how an integrated customer-centric approach should be an essential ingredient of any launch – now, more than ever.
Key topics include:
· Omnichannel as the “booster shot” for post-C19 launches
· The Omnichannel Launch Excellence (O.L.E.) framework explained
· How to translate a global/regional customer-centric O.L.E blueprint into local strategy execution success?
Watch the recorded webinar and access the full deck here: https://bit.ly/3xOkuBs
Kyle Patel (Senior Consultant) and Luisa Schirm (Senior Consultant) will illustrate how to translate your strategic imperatives into a high-impact customer engagement strategy with our Navigator365™ and Scala365™ product suites.
Key topics included:
• How to facilitate the planning and impact measurement phase in the New Normal era with Navigator365™ and Scala365™
• What are some of the key components in boosting your omnichannel capabilities and staying ahead with the ultimate OCE guide?
• How to operate in the post-C19 world with our cloud based OCE product suite
Watch the recorded webinar and access the full deck here: https://bit.ly/3EFsqqJ
Across Health SVP Global Accounts Beverly Smet and Jan Keuppens will demonstrate the latest insights from our Navigator365™ omnichannel affinity research, emphasizing more the significance of a true transformation within pharma organizations in the New Normal era.
Key topics included:
• The impact of covid in the traditional business model, sales & marketing collaboration levels, and the key pharma channels
• What are some of the ingredients required to create a seamless customer experience and how to drive omnichannel customer engagement in the Next Normal?
• How to pump up the digital volume by building an integrated marketing & sales engine for B2B
Watch the recorded webinar and access the full deck here: https://bit.ly/3GFUaNX
In this session, Fonny Schenck (EVP PV&H, MD Across Health) and Pim ten Tusscher (Chief Technology Officer) are lifting the veil on some recent and upcoming advanced uses of Navigator365™, the industry’s leading ecosystem for actionable omnichannel insights, planning, execution and impact tracking.
Key topics include:
• How to “go beyond averages” and compare & contrast subsegments of customers (age, gender, archetype, (sub)specialty,…) -- with just one click!
• A sneak peek into some of the new features & functionalities:
- advanced benchmarking
- advanced time trends
- Payer Navigator365™
- Navigator365™Planner and
- Tracker integration
Watch the recorded webinar and access the full deck on our website: https://bit.ly/3EzgeZo
Christoph Schmidt, Jan Keuppens and Sander Geysen will share the highlights of the 2021 Maturometer survey, which will give you a unique overview of what other life sciences companies are planning and doing in the omnichannel space.
Key topics include:
• Organisational dimension – what’s the sense of urgency? What’s people’s take on the companywide OCE strategy?
• Key investment focus – which channels, technologies, staff capabilities?
• Budget levels for the digital component of the omnichannel mix
• Key barriers
• Key priorities
Watch the recorded webinar and access the full deck on our website: https://bit.ly/3hdARRk
Measuring ROI in life sciences? Not a black & white storyAcross Health
The first results of the 2021 Maturometer confirm that the ROI question is more important than ever. Join Jan Keuppens (SVP Global Accounts) and Christophe Brock (Head of Intelligent Execution & Impact) to learn the value of a solid impact measurement approach: it not only influences key decision-making, but it also contributes to a change of mindset.
Key topics include:
• Why strong impact measurement relies on a strong strategy and business case development
o Impact measurement as key component of campaign and customer journey strategy
• How your omnichannel maturity influences the type & level of KPIs
o Realistic vs “vanity” KPIs
• Understand the continuum between “essential” and “state-of-the-art” KPIs
• Explore examples of how impact measurement influences key decision-making
Watch the recorded webinar and access the full deck on our website: https://bit.ly/3felUMK
Omnichannel upskilling: transforming customer-oriented teams into omnichannel...Across Health
Across Health senior consultants Jean-Sebastien Struyf and Luisa Schirm illustrate the role of Scala365™ and blended learning as a key component of digital transformation at scale within biopharma.
Key topics of this webinar include:
• What type of omnichannel competencies are needed for customer-oriented teams in a post-C19 world - and where is biopharma today?
• “It’s all in the mix” … also for learning styles and formats. How to create a winning learning journey featuring self-paced, blended and hands-on learning - for all key functions?
• How to boost not only knowledge and capabilities, but also change the mindset.
Watch the recorded webinar and access the full deck on our website: https://bit.ly/2RzF0Vu.
The power of marketing & sales collaboration for omnichannel engagementAcross Health
Reimagine the role of customer-facing teams, guided by Beverly Smet (SVP Global Accounts) and Christoph Schmidt (Head of Strategy).
The major takeaways of this webinar include:
• The new commercial model in biopharma: a cross-functional, customer-centric ecosystem
• Roadmap to data-driven omnichannel customer engagement vs the current reality in biopharma
• Case study with demonstrated impact on omnichannel engagement through marketing & sales collaboration
• Key steps for omnichannel engagement success
Watch the recorded webinar and access the full deck on our website: https://bit.ly/2PBTOST
2019-2020: Blip or shift? Key trends in the HCP mixAcross Health
Using relevant insights from our Navigator365 platform, Fonny Schenck (CEO) and David Ziedman (Head of Accounts) will take you back to 2020, explore key shifts vs 2019, and lift a tip of the veil on the Omnichannel Customer Engagement market dynamics you can expect in 2021 and beyond.
Key topics include:
• HCP shifts in channel & content affinity & impact
• HCP interest in & (dis)satisfaction with biopharma’s digital offerings
• Emerging competitor moves
• Future scenarios
Watch the recorded webinar on our website: http://bit.ly/3kUVNNi.
C19: Respond, recover & reimagine the future of HCP engagementAcross Health
And Across Health responded in an agile way to the C19 disruption: we've taken important steps in optimizing the Navigator ecosystem, with over 6,000 HCP respondents since June, insightful COVID-19 questions, new Powertools, upgrades to our integrated OCE Planner Pro, the launch of a DIY “starterkit”, a new OCE capability-boosting platform (SCALA), etc.
Our webinar will take you through the latest Navigator 365 insights, demo the newest Powertools, and show how the data can be used for evidence-based omnichannel HCP journey planning, orchestration, measurement - and ongoing optimization.
Watch the recorded webinar on our website: https://bit.ly/2UmkvcU.
2 years in 2 months? Digital acceleration in biopharmaAcross Health
Relive Across Health first iD.cast: 90 minutes of inspiration on digital acceleration in biopharma
Get food and facts for thought on how biopharma companies can embrace the COVID-19 wake-up call and turn these disruptive times into an opportunity for hyper-acceleration and re-invention. The session featured two highly engaging speakers – and scored an NPS of 65!
- Peter Hinssen, Co-founder Nexxworks, serial entrepreneur, best-selling author, and thought leader on digitalization & innovation
The "VACINE" for the Never Normal and the hourglass model for corporate innovation
- Fonny Schenck, CEO Across Health
2 years in 2 months? Digital acceleration in biopharma
Watch the recorded webinar or download the slides to learn how to be the Phoenix in the biopharma world and create a sustainable competitive superiority: https://bit.ly/2IZDDLv.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
2. Across Health’s Digital Barometer
Know which way the wind blows!
“ For several years now, Across Health has been running a unique digital
landscape survey among life sciences leaders in EMEA. This year’s edition
of the Digital Barometer has taken a global perspective with exclusive
results from our key markets Europe, US and China. It gives you a 360 °
view on the status, challenges and future of “The New Normal” in life
sciences, i.e. when digital communication is no longer new, but is the norm.
I’m convinced you’ll find these results inspiring and trust they will help you
reach the next level...
Thanks again for your participation
and enjoy our hot-off-the-press findings!
Fonny Schenck
Managing Partner, Across Group
CEO, Across Health
8/21/2012 Across Health Digital Barometer 2012 2
3. Table of contents
• Executive summary
• Key survey statistics
• Current adoption of digital
• Benchmark against competitors
• Digital satisfaction
• Most common eTactics
• Key challenges
• Key bottlenecks
• Digital understanding
• The future of digital in life sciences
• Top priorities for digital
• Digital marketing, sales & medical budgets
8/21/2012 Across Health Digital Barometer 2012 3
5. Executive summary
• Overall, we witness a status quo or even a decline
in many areas: digital expertise, HCP multichannel
marketing, ... the first signs that digital is not the
easy „silver bullet‟ many people thought it would be.
• The new focus on cross-channel programmes
however positively points to a more mature use.
• Though digital satisfaction is low, it has improved
compared to previous years.
• Digital budgets continue to be low.
• Standard websites are still most often used.
“It’s not about being
• The top 3 bottlenecks for success continue to be digital anymore, it’s now
regulatory and legal issues, lack of digital about being clever with
strategy and ROI, while lack of headcount and digital.”
lack of budget are gaining ground as obstacles.
Peter Hinssen
8/21/2012 Across Health Digital Barometer 2012 5
6. 8/21/2012 Across Health Digital Barometer 2012 6
8. Key survey statistics
• 358 respondents from life sciences companies
completed the online survey between March
and mid May 2012
• Industry spread
Pharma, Biotech, OTC companies, Medical devices
• Geographical spread
Europe, Middle East & Africa (EMEA), North America
(NA), China (CH), Latin America, Asia Pacific
• Local vs international spread
Global, regional, national / local
• Functional spread
Marketing, Medical, Sales, Digital, IT, CRM, other
8/21/2012 Across Health Digital Barometer 2012 8
9. Most respondents come from pharma
Pharmaceutical company 86%
Medical devices company 5%
Biotechnology company 5%
OTC company 2%
Business consulting 0%
Others 1%
8/21/2012 Across Health Digital Barometer 2012 9
10. The majority operates in the EMEA region
Europe, Middle East & Africa 63%
North America 12%
China 12%
Asia Pacific (exc. China) 7%
Latin America 6%
8/21/2012 Across Health Digital Barometer 2012 10
11. Half of the respondents is working nationally/locally, the other half
works at the regional or global level
Others
2%
Global
21%
National /
local
51%
Regional
27%
8/21/2012 Across Health Digital Barometer 2012 11
12. Functional Spread
Marketing 51%
eBusiness/Digital 30%
IT 11%
Sales 8%
• Marketing and Digital represent
CRM 8%
81% of all answers
• 3 major segments can be defined:
Medical 4%
Sales, Marketing and Medical
eBiz
CRM, IT
Others 15%
8/21/2012 Across Health Digital Barometer 2012 12
13. Current adoption
• Benchmark against other industries and competitors
• Digital satisfaction
• Most common eTactics
8/21/2012 Across Health Digital Barometer 2012 13
14. Current adoption of digital
• The gap with other industries remains.
• Digital initiatives geared towards patients are
generally considered more competitive than
those targeted towards HCPs.
• Satisfaction with digital has improved with
respect to previous years.
• Most commonly used digital tools are classic
eMarketing initiatives, specifically the
product/disease/company website triangle.
“The great thing in the
• Emerging channels like social media and world is not so much
particularly mobile marketing continue to rise – where we stand, as in
with a special mention for iPad/tablet detailing. what direction we are
eRep and eMSL remain small. moving.”
Oliver W. Holmes
8/21/2012 Across Health Digital Barometer 2012 14
15. 57% rate their companies as behind other leading industries when it
comes to optimizing the use of internet
How would you rank your company versus other leading industries
in optimally leveraging the internet?
42%
30%
15%
11%
2% 1%
No opinion Far behind Behind Average Ahead Far ahead
57%
Digital vs other industries
8/21/2012 Across Health Digital Barometer 2012 15
16. In Chinese life sciences companies almost no one feels ahead of other
industries
How would you rank your company versus other leading industries
in optimally leveraging the internet?
40%
39%
36%
31% 30% 9% 7% 32% 2%
28% 27%
17%
7% 7%
3% 2%
1%
EMEA NA CH
No opinion Far behind Behind Average Ahead Far ahead
Digital vs other industries
Note: EMEA: Europe, Middle East & Africa - NA: North America - CH: China
8/21/2012 Across Health Digital Barometer 2012 16
17. In EMEA, the share of respondents believing that life sciences is far behind
decreases over time, while the percentage thinking they are ahead is more or
less stable
How would you rank your company versus other leading industries
in optimally leveraging the internet?
60%
41% 40%
40% 6% 9% 36% 13% 9%
33% 33% 31% 31%
25%
24% 23%
20% 17%
15% 12%
6% 8% 7%
4% 3% 3% 3% 2%
1% 1%
0%
2009 2010 2011 2012
No opinion Far behind Behind Average Ahead Far ahead
Digital vs other industries
8/21/2012 Across Health Digital Barometer 2012 17
18. Digital Strategy
in the New Normal
“
Once we cross over into the times where digital is the New Normal,
the way we interact with our customers will change completely. The
worst mistake you could make is to take your existing analog
interaction patterns with customers and transfer them to the web.
Don’t transfer, but re-think. It’s all about intelligence. It’s all about
the contact, it’s all about “you”.
As the master of marketing, Philip Kotler, once said: “Marketing
takes a day to learn. Unfortunately it takes a lifetime to master.”
You’ve got a couple of years, max.”
Peter Hinssen
Chairman, Across Technology
Author of the best-selling “The New Normal”
8/21/2012 Across Health Digital Barometer 2012 18
19. 1 out of 4 rank their company ahead of competition in using digital
marketing towards HCPs
How would you rank your company versus your competitors in using digital marketing
initiatives targeted at healthcare professionals?
HCPs
40%
25%
26%
23%
6%
3% 2%
No opinion Far behind Behind Average Ahead Far ahead
8/21/2012 Across Health Digital Barometer 2012 19
20. Companies in North America feel more confident when it comes to using
digital marketing towards HCPs
How would you rank your company versus your competitors in using digital marketing
initiatives targeted at healthcare professionals?
HCPs 45%
40% 9% 24% 13%
31% 31%
27%
25% 24%
23%
14%
11%
10%
7%
5%
3% 2% 2%
EMEA NA CH
No opinion Far behind Behind Average Ahead Far ahead
Note: EMEA: Europe, Middle East & Africa - NA: North America - CH: China
8/21/2012 Across Health Digital Barometer 2012 20
21. Remarkably, the confidence of mastering multichannel HCP marketing is
decreasing strongly over time... while the need to do so is rising year
after year (EMEA data)
How would you rank your company versus your competitors in using digital marketing
initiatives targeted at healthcare professionals?
HCPs 26% 19% 15% 9%
39% 40%
38%
31% 31%
25% 26% 25%
23% 23%
16% 17%
13% 13%
7% 7% 7%
3% 4% 2% 3%
1% 2% 2%
2009 2010 2011 2012
No opinion Far behind Behind Average Ahead Far ahead
8/21/2012 Across Health Digital Barometer 2012 21
22. In terms of consumer / patient-driven digital marketing initiatives,
17% ranked their companies as ahead of competition...
How would you rank your company versus your competitors in using digital marketing
initiatives targeted at consumers/patients?
Patients
17%
39%
27%
14%
12%
4%
3%
No opinion Far behind Behind Average Ahead Far ahead
8/21/2012 Across Health Digital Barometer 2012 22
23. … with again a higher level of confidence in North American companies
compared to the other regions
How would you rank your company versus your competitors in using digital marketing
initiatives targeted at consumers/patients?
Patients 48%
43%
39% 19% 21% 16%
27%
24%
21% 20%
18%
14% 14%
12%
5% 7%
3% 2% 2%
EMEA NA CH
No opinion Far behind Behind Average Ahead Far ahead
Note: EMEA: Europe, Middle East & Africa - NA: North America - CH: China
8/21/2012 Across Health Digital Barometer 2012 23
24. Opposite to the trend for HCP digital initiatives, more EMEA companies
feel ahead of competition in using digital towards patients
How would you rank your company versus your competitors in using digital marketing
initiatives targeted at consumers/patients?
Patients
39%
36%
32% 32% 31% 33%
30%
9% 15% 17% 27% 19%
23%
14% 13% 15% 14%
13% 12%
8% 7%
4% 5%
3% 2% 2% 3%
1%
2009 2010 2011 2012
No opinion Far behind Behind Average Ahead Far ahead
8/21/2012 Across Health Digital Barometer 2012 24
25. Comparing regions once more, it is clear that the level of confidence in North
America is much higher than in other regions, especially regarding HCP
communication
How would you rank your company versus your competitors in using digital marketing
initiatives targeted at HCPs OR consumers/patients? (% ahead + % far ahead)
40%
28% 45% 30%
24%
21%
20% 19%
16%
14%
9%
0%
EMEA NA CH
HCP Patients
Note: EMEA: Europe, Middle East & Africa - NA: North America - CH: China
8/21/2012 Across Health Digital Barometer 2012 25
26. The iPad (r)evolution
“ For long, we all have been using legacy CRM systems and some of us have even
tried out tablet computers in day-to-day calls. It almost started to seem normal
practice to work with the slow and heavy tools we had. But then the iPad (and cloud
computing) took us all by surprise.
Still today, almost weekly companies are approaching us with the same question:
“We just bought iPads... how do we go beyond the rapidly waning novelty factor –
and PDF detail aids?” And this is only the start...
Indeed, the iPad holds a lot of promise for integrated cross-channel approaches. But
the tool itself is already being commoditized... If done well, interactive detailing can
quickly become the main gateway for reps and their customers to access the
company’s whole multichannel service offering. In that scenario, the iPad can
completely change the way we have been doing business for decades in
just a few years... If not, it will be just another technology-led hype... and
the track record of pharma is not really strong in this area!
Pat Thistlethwaithe
Managing Director, USA
8/21/2012 Across Health Digital Barometer 2012 26
27. Only 17% of respondents are satisfied with their current digital activities
On a scale from 0 to 5, how satisfied are you with your current digital activities?
42%
30%
17%
15%
11%
1% 2%
0 1 2 3 4 5
Extremely Extremely
Dissatisfied Satisfied
Average
score 2,6
8/21/2012 Across Health Digital Barometer 2012 27
28. Respondents in EMEA and NA regions report satisfaction levels of
around 17%, while China’s is much lower
On a scale from 0 to 5, how satisfied are you with your current digital activities? AVG. Score
2%
EMEA 13% 28% 41% 15% 2,6
2%
NA 2 5 43% 33% 14% 2,6
CH 5% 7% 50% 36% 2%
2,3
0% 20% 40% 60% 80% 100%
Extremely 0 1 2 3 4 5 Extremely
Dissatisfied Satisfied
Note: EMEA: Europe, Middle East & Africa - NA: North America - CH: China
8/21/2012 Across Health Digital Barometer 2012 28
29. The EMEA region records a gradual increase in digital satisfaction over
the years, with a marked increase over the last year…although the
absolute number remains low.
On a scale from 0 to 5, how satisfied are you with your current digital activities?
2%
2012 13% 28% 41% 15%
1%
2011 2 18% 34% 34% 11%
2010 4% 18% 34% 32% 10% 2%
2%
2009 5% 24% 26% 35% 8%
0% 20% 40% 60% 80% 100%
Extremely 0 1 2 3 4 5 Extremely
Dissatisfied Satisfied
8/21/2012 Across Health Digital Barometer 2012 29
30. Digital strategy in China
“ Although China is set to be the second largest market for pharmaceuticals within
the next few years... and already has almost twice as many internet users as the
number 2 market, the United States... the cross-channel potential remains largely
untapped. With around two million doctors and massive sales forces serving only
5% of this fast broadening market, doctors remain largely underinformed and
undereducated. The potential for digital (or multichannel) programmes is huge...
Considering both the budgets and the stakes are high, pharmaceutical
companies cannot permit themselves to “understrategize”. Unfortunately, this
tends to run against the rather implementation focused Chinese mindset. This is
a call to do something about it. Sound insights, strategic planning and the right
impact measurement are all key for success. As in many other situations, the
chain is only as strong as its weakest link.
Francis Chay
Managing Director, China
8/21/2012 Across Health Digital Barometer 2012 30
31. Classic websites remain the most commonly used digital channels on both
a global and regional level. Mobile and particularly tablet detailing are
moving up the ranks fast, while social media seems to lose momentum.
Company website 88% 5% 5% 3
Product website 72% 15% 9% 4%
Disease website 66% 14% 14% 5%
eMail marketing 58% 22% 14% 6%
Web banners 53% 16% 23% 8%
Tablet eDetailing 46% 33% 17% 5%
Web conference 44% 32% 20% 4%
HCP self-service portal 43% 28% 21% 8%
SEO 43% 23% 23% 11%
Online MedEd 41% 30% 21% 8%
SEA 41% 20% 28% 11%
Mobile marketing 28% 46% 22% 4%
Virtual eDetailing 22% 36% 34% 8%
Social media 18% 38% 40% 4%
eMSL 11% 27% 48% 13%
eRep 11% 36% 44% 9%
Often / Standard practice Pilot planned or ongoing
Never Do not know / NA
8/21/2012 Across Health Digital Barometer 2012 31
32. A cross-region comparison shows...
• The top 5 eTactics are consistent across regions and are
classic eMarketing tools
• The upcoming stars immediately follow: tablet edetailing is
the number 6 in EMEA, while in North America HCP self-
service portals are more widely adopted
• SEO & SEA are bigger in North America, most probably due
to the larger importance of consumers
• Mobile marketing is most used in the Chinese market
• Surprisingly the EMEA market scores better in terms of
Online MedEd and web conferences than the MedEd-loving
Chinese market
• The promising eMSL and eRep initiatives are still not taking
off on a large scale
8/21/2012 Across Health Digital Barometer 2012 32
33. Top eTactics used in:
Europe, Middle East and Africa
Company website 86% 6% 6% 2
Product website 69% 16% 12% 3%
Disease website 63% 17% 15% 4%
eMail marketing 58% 22% 14% 6%
Web banners 52% 16% 26% 7%
Tablet eDetailing 48% 34% 16% 1
HCP self-service portal 42% 30% 23% 6%
Online MedEd 42% 30% 23% 5%
Web conference 40% 35% 23% 2
SEO 39% 23% 27% 11%
SEA 34% 21% 32% 12%
Mobile marketing 24% 47% 26% 3
Virtual eDetailing 22% 34% 38% 5%
Social media 13% 37% 48% 3
eRep 10% 38% 48% 4%
eMSL 10% 24% 55% 11%
Often / Standard practice Pilot planned or ongoing
Never Do not know / NA
8/21/2012 Across Health Digital Barometer 2012 33
34. Top eTactics used in:
North America
Company website 88% 2 7% 2
Product website 81% 10% 7% 2
Disease website 62% 12% 17% 10%
eMail marketing 62% 10% 17% 12%
Web banners 60% 10% 12% 19%
HCP self-service portal 55% 14% 19% 12%
SEO 52% 10% 17% 21%
SEA 52% 12% 17% 19%
Web conference 43% 24% 17% 17%
Tablet eDetailing 43% 31% 19% 7%
Online MedEd 33% 12% 24% 31%
Mobile marketing 33% 48% 14% 5%
Virtual eDetailing 26% 24% 38% 12%
Social media 24% 43% 26% 7%
eRep 17% 19% 50% 14%
eMSL 14% 17% 38% 31%
Often / Standard practice Pilot planned or ongoing
Never Do not know / NA
8/21/2012 Across Health Digital Barometer 2012 34
35. Top eTactics used in:
China
Company website 86% 9% 2 2
Product website 68% 23% 5% 5%
Disease website 61% 20% 14% 5%
eMail marketing 48% 32% 14% 7%
Web banners 45% 25% 25% 5%
SEO 41% 32% 23% 5%
SEA 41% 27% 27% 5%
Mobile marketing 39% 45% 14% 2
HCP self-service portal 36% 32% 25% 7%
Web conference 36% 30% 30% 5%
Online MedEd 32% 36% 25% 7%
Social media 30% 36% 34%
Tablet eDetailing 27% 39% 23% 11%
Virtual eDetailing 16% 36% 36% 11%
eMSL 11% 30% 50% 9%
eRep 9% 20% 57% 14%
Often / Standard practice Pilot planned or ongoing
Never Do not know / NA
8/21/2012 Across Health Digital Barometer 2012 35
36. In EMEA, the highest increase compared to previous years occurs for
tablet edetailing and mobile marketing
100% Often / Standard Practice
90%
80%
2010 2011 2012
70%
60%
50%
40%
30%
20%
10%
0%
8/21/2012 Across Health Digital Barometer 2012 36
37. As the use of web banners becomes more of a standard practice, piloting
efforts for this digital tool slow down. On the other hand, eMSL and eRep are
piloted more often each year
50% Pilot Planned / Ongoing
2010 2011 2012
40%
30%
20%
10%
0%
8/21/2012 Across Health Digital Barometer 2012 37
38. eRep and eMSL
require thoughtful management
“ The traditional business model in pharma is waning. The role of the
sales force is being redefined and their tools modernized, as iPad
detailing and remote live customer interactions, a.k.a. eRep and eMSL,
are being introduced. As opposed to the amount of attention iPad
detailing currently gets, the more disruptive and potentially more
impactful remote approaches are still only used by a limited group of
early adopters.
Indeed, introducing remote detailing requires more courage,
investment and change management. Our experience teaches us that
it is truly about changing the business model step by step – any other
approach will quickly fail and die, leaving behind a wound in the
organization that is hard to heal.
Patrick Vidal
Managing Director, France
8/21/2012 Across Health Digital Barometer 2012 38
39. Finally, in the mobile space, “beyond the pill” still seems a far cry from
reality… product info apps are most commonly developed; the promising
monitoring tools seem to be the hardest
MOBILE: What apps / tactics do you develop or have developed?
Product info / updates 41%
Mobile website 30%
Medical news / article updates 28%
Adherence / compliance tracker 27%
Dosage calculator 26%
Diagnostic tool 25%
Treatment guidelines 25%
CME 24%
Symptom tracker 11%
Remote monitoring of patients 9%
Others 4%
None 22%
8/21/2012 Across Health Digital Barometer 2012 39
40. Key challenges
• Key bottlenecks
• Digital understanding
8/21/2012 Across Health Digital Barometer 2012 40
41. Key challenges
• Regulatory or legal issues, lack of digital
strategy, and ROI are still the main challenges.
• Lack of headcount and lack of budget are
rising to the top – a sign that companies are finally
starting to right-resource the cross-channel
opportunity?
• Lack of internal knowledge is relatively more
important in EMEA. North America focuses more
on resource issues and China on ROI concerns.
• More than half feel they have insufficient
knowledge of all online opportunities for their “When you're finished
business activities... and this number has been changing, you're
going down rather than up in the past few years. finished.”
Benjamin Franklin
8/21/2012 Across Health Digital Barometer 2012 41
42. The 3 primary bottlenecks for digital are regulatory issues, ROI questions
and unclear eBusiness strategies
Regulatory or legal issues 25% 18% 8%
ROI questions 17% 11% 11%
No clear eBusiness strategy 18% 11% 9%
Not enough internal knowledge in this area 9% 10% 12%
No headcount to support this 6% 7% 12%
Healthcare compliance concerns 6% 10% 6%
No budget 4% 8% 9%
No senior management support 4% 6% 6%
Pharmacovigilance issues adverse event reporting etc 3% 5% 6%
Customers are not ready 3% 4% 4%
No expert agencies with pharma background available 1 3 4%
Others 2 21
NA 1 4% 11%
Most important Second most important Third most important
8/21/2012 Across Health Digital Barometer 2012 42
43. The same top 3 reigns supreme in EMEA. Lack of internal knowledge is
rising quickly…
Europe, Middle East and Africa
Regulatory or legal issues 26% 20% 8%
No clear eBusiness strategy 19% 10% 9%
ROI questions 16% 11% 10%
Not enough internal knowledge in this area 9% 12% 15%
No headcount to support this 8% 7% 11%
Healthcare compliance concerns 7% 10% 6%
No budget 3% 6% 9%
No senior management support 4% 5% 6%
Pharmacovigilance issues adverse event reporting etc 2 5% 6%
Customers are not ready 3 4% 5%
No expert agencies with pharma background available 2 3%
Others 2 3 1
NA 1 4% 11%
Most important Second most important Third most important
8/21/2012 Across Health Digital Barometer 2012 43
44. Again, the same top 3 holds for North America. Resource issues
(budget/headcount/knowledge) are important runner-ups here
North America
Regulatory or legal issues 43% 14% 10%
ROI questions 7% 12% 19%
No clear eBusiness strategy 17% 12% 7%
No budget 7% 12% 12%
No headcount to support this 5% 14% 10%
Not enough internal knowledge in this area 10% 7% 10%
Healthcare compliance concerns 7% 12% 5%
Pharmacovigilance issues adverse event reporting etc 2 7% 7%
No senior management support 2 7% 7%
No expert agencies with pharma background available 2 5%
Customers are not ready 2
Others 2
NA 5%
Most important Second most important Third most important
8/21/2012 Across Health Digital Barometer 2012 44
45. Also in China the top 3 is the same. However, ROI questions are much
more prominent, while regulatory/legal issues come in only 3rd…
China
ROI questions 32% 16% 14%
No clear eBusiness strategy 14% 18% 11%
Regulatory or legal issues 11% 16% 5%
Not enough internal knowledge in this area 14% 5% 9%
No budget 7% 11% 9%
No senior management support 7% 7% 9%
Healthcare compliance concerns 5% 9% 9%
Customers are not ready 5% 9% 2
No headcount to support this 22 11%
No expert agencies with pharma background available 22 9%
Pharmacovigilance issues adverse event reporting etc 22
Others 2
NA 2 9%
Most important Second most important Third most important
8/21/2012 Across Health Digital Barometer 2012 45
46. In EMEA, the top 2 receded as a bottleneck giving way to resource topics
(lack of internal knowledge, low budgets, lack of headcount)
Regulatory or legal issues
No clear eBusiness strategy
ROI questions
Not enough internal knowledge in this area
Healthcare compliance concerns
No headcount to support this
No senior management support 2012 2011 2010
No budget
Customers are not ready
Pharmacovigilance issues adverse event reporting etc
No expert agencies with pharma background available
Others
NA
0% 10% 20% 30% 40% 50% 60% 70%
8/21/2012 Across Health Digital Barometer 2012 46
47. Only slightly more than 1 out of 3 respondents feels confident about their
digital expertise
Do you feel that you have sufficient knowledge of all opportunities offered by the internet for
your business activities?
38%
44%
30%
18%
8%
1%
Totally Insufficient Between Sufficient More than
insufficient sufficient sufficient /
and expert
insufficient
Internal knowledge
8/21/2012 Across Health Digital Barometer 2012 47
48. Setting up the multichannel organization
“ When organizing your company for integrated cross-channel and customer
centric approaches, a lot of small and big steps need to be taken, and
sometimes retaken.
Zero-based definition of the channel mix, upgrading the CRM platform for true
360° CLM, introducing new sales tools, training & change management,
synchronizing sales-marketing-service-medical teams, investing in customer
analytics, building the required digital infrastructure, defining new policies and
processes, ... It requires considerable vision, experienced people and a
willingness to keep moving forward.
The production agencies of the past – who recently acquired digital
capabilities – are no appropriate partners to take along in this transformation.
We believe in multichannel, and we’ve been there. Have a look at our website
and give us a call!
Patric Jarchow
Managing Director, Germany
8/21/2012 Across Health Digital Barometer 2012 48
49. The future of digital
in life sciences
• Top priorities for digital
• Digital marketing, sales & medical budgets
8/21/2012 Across Health Digital Barometer 2012 49
50. FUTURE
OF DIGITAL
The future of digital
in life sciences
• Cross-channel marketing mix optimization is
the top priority for most. Strategy development and
impact measurement/dashboarding immediately
follow.
• Currently, digital initiatives capture only a small
percentage of the total marketing budget. For
medical and sales this is even lower.
• 3 out of 4 believe the digital budget will increase
– but only moderately (and still too slowly to really
change something). Meanwhile, the majority
“My interest is in the
believes that the overall marketing budget will future because I am
either remain the same or decrease. going to spend the rest
of my life there.”
Charles F. Kettering
8/21/2012 Across Health Digital Barometer 2012 50
51. FUTURE
OF DIGITAL
Overall, cross-channel marketing optimization is the most important
digital priority while assessing landscape trends comes in last
What are priorities in your organization regarding DIGITAL?
Cross-channel marketing mix
20%
optimization
Strategy development 18%
Impact measurement / reporting /
15%
dashboarding
Full-scale execution of tactics 14%
Training 14%
Best practice sharing 12%
Assessing landscape trends 8%
8/21/2012 Across Health Digital Barometer 2012 51
52. FUTURE
OF DIGITAL
Marketing mix optimization leads in EMEA. On the other hand, full-scale
execution of tactics is NA’s priority while CH focuses on impact
measurement and strategy
EMEA NA CH
Cross-channel marketing 17% 15%
22%
mix optimization
Strategy development 18% 16% 16%
Impact measurement / 16% 16%
15%
reporting / dashboarding
Full-scale execution of 18% 15%
13%
tactics
Training 13% 15% 15%
Best practice sharing 11% 10% 13%
Assessing landscape 7% 8% 9%
trends
Note: EMEA: Europe, Middle East & Africa - NA: North America - CH: China
8/21/2012 Across Health Digital Barometer 2012 52
53. Rethink the marketing mix
“ When reading the Digital Barometer results, it strikes and delights me that
this year’s top priority regarding digital is the redefinition of the cross-channel
marketing mix.
It is truly essential to rethink the cross-channel mix, as it is only when you
visualize your optimal mix from the eye of your customers, calculate budgets
and resources accordingly, and redesign your customer-facing activities, that
you will be able to lead the required change, generate true business impact...
and create a virtuous circle of success.
Even if the large cross-channel breakthrough may not come before
2013-2015, visualize it today and plan for the near future. It will be a
helpful map in your exciting journey in the “New Normal”...and any
procrastination is to be avoided – your competitors have the same
priority!
Charles MacKinnon
Managing Director, UK
8/21/2012 Across Health Digital Barometer 2012 53
54. FUTURE
OF DIGITAL
Marketing budget for digital initiatives continues to go up year after year
If you oversee a product budget (marketing), which percentage of it is allocated to digital
initiatives THIS YEAR?
less than 5% Average
14,1%
41%
5% to 10%
11% to 15%
17% 16%
16% to 20% 12%
9%
6%
21% to 25%
more than 25%
Digital marketing
8/21/2012 Across Health Digital Barometer 2012 54
55. FUTURE
OF DIGITAL
Across regions, the digital marketing budget is approximately the same.
China has relatively more budgets below 10%
If you oversee a product budget (marketing), which percentage of it is allocated to digital
initiatives THIS YEAR?
Average 42%
14,8% Average
36% Average
14,2%
15,4%
29%
24%
22%
19%
17% 18%
15%
12% 12% 12%
9% 9%
7% 8%
6%
4%
EMEA NA CH
less than 5% 5% to 10% 11% to 15% 16% to 20% 21% to 25% more than 25%
Digital marketing
8/21/2012 Across Health Digital Barometer 2012 55
56. FUTURE
OF DIGITAL
In EMEA, the reported budget for digital marketing jumped compared to
2011. This is most probably due to our new budget split in the survey (now
additionally into medical and sales budgets).
If you oversee a product budget (marketing), which percentage of it is allocated to digital
initiatives THIS YEAR?
54%
52%
46%
Average
7%
less than 5% 36%
31% 30%
5% to 10% 24% Average
14,8%
more than 10% 17%
Average
8%
9%
2010 2011 2012
Digital marketing
8/21/2012 Across Health Digital Barometer 2012 56
57. FUTURE
OF DIGITAL
Medical budgets do not prioritize digital initiatives. Digital is however
slowly taking off
If you oversee a product budget (medical), which percentage of it is allocated to digital
initiatives THIS YEAR?
less than 5% 49%
5% to 10%
Average
34%
9,7%
11% to 15%
16% to 20%
21% to 25%
6%
4% 4%
3%
more than 25%
Digital medical
8/21/2012 Across Health Digital Barometer 2012 57
58. FUTURE
OF DIGITAL
Compared to other regions, China is far ahead in terms of budget for
digital medical initiatives
If you oversee a product budget (medical), which percentage of it is allocated to digital
initiatives THIS YEAR?
50% 50%
46%
41% Average
8,9% Average
Average 12,4%
8,6%
25% 25%
22%
11% 11%
5% 6%
3% 3% 4%
EMEA NA CH
less than 5% 5% to 10% 11% to 15% 16% to 20% 21% to 25% more than 25%
Digital medical
8/21/2012 Across Health Digital Barometer 2012 58
59. FUTURE
OF DIGITAL
Similarly, digital sales budgets are also quite low, but rising
If you oversee a product budget (sales), which percentage of it is allocated to digital initiatives
THIS YEAR?
less than 5%
47%
5% to 10%
34% Average
9,4%
11% to 15%
16% to 20%
7% 5%
3% 4%
21% to 25%
more than 25%
Digital sales
8/21/2012 Across Health Digital Barometer 2012 59
60. FUTURE
OF DIGITAL
North America spends the most on digital initiatives linked to sales
If you oversee a product budget (sales), which percentage of it is allocated to digital initiatives
THIS YEAR?
60% Average
8,5%
48%
44%
40%
38%
Average
28%
Average 11,7%
9,6%
17%
6% 6% 6%
4% 4%
1%
EMEA NA CH
less than 5% 5% to 10% 11% to 15% 16% to 20% 21% to 25% more than 25%
Digital sales
8/21/2012 Across Health Digital Barometer 2012 60
61. FUTURE
OF DIGITAL
Only 25% reported that the general marketing budget will increase, while
75% of respondents foresee an increase of their digital budget
How do you think your overall marketing budget and digital budget will evolve?
55%
Overall
43% Digital
28%
21%
19%
13%
3% 5% 4%
1% 2% 1% 3%
1%
Decrease Decrease Stay the Increase by Increase by Increase by Will more
>25% <25% same <20% 21% to 50% >50% than double
8/21/2012 Across Health Digital Barometer 2012 61
62. Life sciences spending on digital
“ In terms of digital budget in life sciences, we’ve come a long way. Still, a
14,1% digital marketing budget is nothing more than a “good start”, even
despite the double-digit yearly growth from a low base...14.1% is not at all
reflecting the true potential of the new channels and customer expectations!
The companies that are really changing the game tend to be the ones that
are forced to. Only if resources need to be reallocated to other products or
traditional approaches do not cut it anymore, bold moves towards a
multichannel approach are made.
My question is: why do we wait for circumstances to get critical to review the
way we spend our marketing-sales budgets? Why don’t we embrace the
New Normal and really rethink the way we do business from the customer’s
perspective?
Eva Velasco
Managing Director, Spain
8/21/2012 Across Health Digital Barometer 2012 62
64. So will 2013 go on record as
the first year in the New Normal?
“ Some Barometer trends could certainly tempt me into answering with a strong “YES”.
Indeed, there are several positive signs for a higher level of cross-channel maturity:
the importance of internal knowledge/resources is on the rise, budgets are increasing
and cross-channel marketing and robust execution are seen as key priorities.
On the other hand, the limited overall spend on digital, the incessant focus on ROI,
the strong focus on ipad detailing (which is already becoming a commodity and not
solving some bigger issues), the product-centric approach to mobile and the limited
overall knowledge, despite many well-intended training efforts and pilot projects, lead
me to say: probably not until 2014...
Nevertheless, many enlightened teams and greenfield companies will continue to
lead the way and change the game...good luck on your journey towards the New
Normal!
Fonny Schenck
Managing Partner, Across Group
CEO, Across Health
8/21/2012 Across Health Digital Barometer 2012 64
65. About Across Health
COMPANY
• 60+ strong consultancy
• Focus on innovative customer-centric approaches
(e-powering traditional channels– “fusion”)
• From insight to innovation strategy, integrated execution
& impact measurement
• Unique offering in the industry
• 35+% CAGR since the start (2007)
CUSTOMERS
Extensive experience at
• Pharmaceuticals regional/global level
• Devices & Diagnostics
• Hospitals AND
• Patient & Professional Associations
local execution power
INTERNATIONAL EXPANSION ONGOING
• Head offices in Belgium (Ghent)
• Offices in Spain, France, UK, Switzerland, Netherlands,
Nordics, Germany, New Europe, China, Australia and US
8/5/12 Across Health Digital Barometer 2012 65
66. How do we play?
04
Impact
01 Insight
We summarize key trends, best
practices and benchmarks - also
from related and other industries -
and compare them to your current
We measure the impact of the new
situation.
strategy using dashboards, KPIs,
… and create best-practice
The 4 Is
documents/tools.
Integrated
execution 03
We handle the project from A to Z as
02
Innovation
We come up with a 2-3 year
innovative, balanced and integrated
roadmap and strategy for the
well as supporting in related activities program that builds on the strenghts of
such as change management, process your existing channels.
& organizational development, design,
training of sales reps, etc.
8/21/2012 Across Health Digital Barometer 2012 66
67. We advocate a balanced approach
Experiment
Enhance • Mobile strategy &
Execute • Dashboards tactics
• (on-site) programme • Customer experience • Social strategy &
management of large- tactics
• Online marketing
scale projects: cross- • PHR/EHR strategy
• Personalization
channel projects, • Innovation pilots
teledetailing, self- • Search engine
service portal, … optimization
• Social media
optimization
• …
21-8-2012 Across Health - Introduction 67
68. Some of our key references
8/21/2012 Across Health Digital Barometer 2012 68
70. Contact Details
DISCLAIMER: These results have been compiled by Jeroen Corthout & Fadi Baddur
Current presentation is confidential. All For any question, mail to jeroen.corthout@a-cross.com
proposed concepts and ideas Make sure also to check out our fields of expertise on
presented here are intellectual property
of Across Health, and are to be used in
collaboration with Across Health. www.a-cross.com/health